Loss of NF1 in Melanoma Confers Sensitivity to SYK Kinase Inhibition.

Cara Abecunas, Christy L Frankowski-Mcgregor + Show 5 more

Open Access

https://doi.org/10.1158/0008-5472.can-22-0883

Copy DOI

Journal: American Journal of Cancer	Publication Date: Nov 21, 2022
Citations: 4	License type: CC BY-NC-ND 4.0

Abstract

A kinase inhibitor screen identifies SYK as a targetable vulnerability in melanoma cells with NF1 loss of function.

Full Text

Published version (

Free)

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Paper Title

Journal

Date

Author